Covid-19 Outbreak Response combining E-health, Serolomics, Modelling, Artificial Intelligence and Implementation Research

This project aims to close existing gaps between clinical, epidemiological and immunological information in order to better respond to the Covid-19 pandemic. European researchers from the Netherlands, Switzerland and Germany, as well as partners from China, Ivory Coast and Nepal are working together to achieve this goal. In addition, existing cross- or partial immunity against SARS-CoV-2 is to be investigated in Germany and Nepal. The data collected will help to better assess the transmission of the virus and evaluate the effectiveness of measures against its spread.

Overview of SARS-COV-2 studies seroprevalence in context of the worldwide  COVID-19 pandemie. You can register a study here: Contribute
@serohub on Twitter
hzi-braunschweig/serohub on GitHub